Hostname: page-component-745bb68f8f-f46jp Total loading time: 0 Render date: 2025-01-22T11:04:53.105Z Has data issue: false hasContentIssue false
  • English
  • Français

An Early Historical Perspective on the FDA's Regulation of OTC Drugs

Published online by Cambridge University Press:  21 June 2016

Mary K. Bruch  and
Elaine Larson
Get access Rights & Permissions [Opens in a new window]

Extract

From a variety of contacts with hospital infection control personnel, it has become clear to us that the historical perspective about and internal workings of the Food and Drug Administration (FDA) are confusing and deserve clarification. The accompanying article in this issue (“Regulation of TopicalAntimicrobials: History, Current Status and Future Perspective,” pp. 505-508) details the regulation of topical antimicrobial drugs administered by the FDA. We believe it is necessary to provide a special context for this article.

Type
Special Sections
Information
Infection Control & Hospital Epidemiology , Volume 10 , Issue 11 , November 1989 , pp. 527 - 528
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1989

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Janssen, R. America's first food and drug laws. Food and Drug Cosmetics Law Journal. 1975;30:665–666.Google Scholar